Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on March 21, 2007
J Am Soc Nephrol 18: 1284-1291, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006101102

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
ASN.2006101102v1
18/4/1284    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hadjadj, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hadjadj, S.
Related Collections
Right arrowRelated Article

Human Genetics

Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy: Case-Control, Haplotype, and Family-Based Study in Three European Populations

Samy Hadjadj*, Lise Tarnow{dagger}, Carol Forsblom{ddagger}, Gbenga Kazeem§, Michel Marre||, Per-Henrik Groop{ddagger}, Hans-Henrik Parving{dagger}, François Cambien, David A. Tregouet, Ivo G. Gut**, Alexandre Théva, Dominique Gauguier§, Martin Farrall§, Roger Cox{dagger}{dagger}, Fumihiko Matsuda**, Mark Lathrop**, FinnDiane Study Group, Nathalie Hager-Vionnet for the EURAGEDIC (European Rational Approach for the Genetics of Diabetic Complications) Study Group

* CHU de Poitiers, Department of Diabetology, and INSERM ERM 324, Poitiers University Hospital, Poitiers, France; {dagger} Steno Diabetes Center, Copenhagen, Denmark; {ddagger} Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, and Helsinki University Central Hospital, Department of Medicine, Division of Nephrology, Helsinki, Finland; § Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom; || INSERM U695, Xavier Bichat University of Medicine, and Department of Diabetology, Bichat Hospital, Paris, France; INSERM and Université Pierre et Marie Curie-Paris 6, UMR S 525, Paris, France; ** Centre National du Genotypage, Evry, France; and {dagger}{dagger} Mammalian Research Council, Oxford, United Kingdom

Address correspondence to: Dr. Samy Hadjadj, Department of Diabetology, Poitiers University Hospital, BP 577, 86021 Poitiers Cedex, France. France: +33-5-49-44-39-00; Fax: +33-5-49-44-40-06; s.hadjadj{at}chu-poitiers.fr

Received for publication October 10, 2006. Accepted for publication February 2, 2007.

Angiotensin 1-converting enzyme gene (ACE) is a risk factor for diabetic nephropathy (DN) in patients with type 1 diabetes. The selection of this candidate gene is supported by cross-sectional and follow-up studies, but no convincing family-based studies are available. Recruited were 1057 patients (with DN: persistent albuminuria with or without renal failure) and 1127 control subjects (long-standing [≥15 yr] normoalbuminuric patients with type 1 diabetes) in Denmark, Finland, and France and 532 family trios that were composed of 244 trios with DN probands and 288 trios with non-DN probands. Five ACE polymorphisms were studied. In the case-control analysis, the rs1800764-C, rs4311-T, Insertion/deletion (I/D or rs1799752)-D, rs4366-G, and rs12449782-G alleles were associated with an increased risk for DN, homogeneously across populations, with allelic odds ratios of 1.11 (95% confidence interval 1.00 to 1.22), 1.18 (1.04 to 1.33), 1.13 (1.02 to 1.23), 1.10 (0.99 to 1.20), and 1.12 (1.01 to 1.23), respectively. Haplotype analysis further demonstrated that the haplotype defined by the D, rs4366_G and rs12449782_G alleles was associated with a greater risk for DN. Even though no significant allelic overtransmission to DN or non-DN probands was detected, the family-based study provided consistent results with the case-control analysis. In a large case-control study, it was shown that the ACE polymorphisms were associated with DN; these findings were not confirmed in a family-based association study. This study population is suitable to search for additional candidate genes for DN.


Related Article

This Month’s Highlights
J. Am. Soc. Nephrol. 2007 18: 1021-1022. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Diabetes CareHome page
D. P.K. Ng
Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects: Results From the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) Studies: Response to Hadjadj et al.
Diabetes Care, October 1, 2008; 31(10): e78 - e78.
[Full Text] [PDF]


Home page
Diabetes CareHome page
S. Hadjadj, R. Roussel, M. Marre, and for the DIABHYCAR, DIAB2NEPHROGENE, AND SURDIAGENE
Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects: Results From the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) Studies: Response to Ng et al.
Diabetes Care, October 1, 2008; 31(10): e79 - e79.
[Full Text] [PDF]


Home page
CJASNHome page
P. Ruggenenti, P. Bettinaglio, F. Pinares, and G. Remuzzi
Angiotensin Converting Enzyme Insertion/Deletion Polymorphism and Renoprotection in Diabetic and Nondiabetic Nephropathies
Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1511 - 1525.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. P.K. Ng, B.-C. Tai, and X.-L. Lim
Is the Presence of Retinopathy of Practical Value in Defining Cases of Diabetic Nephropathy in Genetic Association Studies?: The Experience With the ACE Insertion/Deletion Polymorphism in 53 Studies Comprising 17,791 Subjects
Diabetes, September 1, 2008; 57(9): 2541 - 2546.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Granier, K. Makni, L. Molina, B. Jardin-Watelet, H. Ayadi, and F. Jarraya
Gene and protein markers of diabetic nephropathy
Nephrol. Dial. Transplant., March 1, 2008; 23(3): 792 - 799.
[Full Text] [PDF]


Home page
CJASNHome page
B. I. Freedman, M. Bostrom, P. Daeihagh, and D. W. Bowden
Genetic Factors in Diabetic Nephropathy
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1306 - 1316.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP